April 14, 2009

IN RE: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation

Track this case

Case Number:

1:09-md-02023

Court:

New York Eastern

Nature of Suit:

Fraud or Truth-In-Lending

Multi Party Litigation:

Multi-district Litigation

Judge:

Brian M. Cogan

Firms

Companies

Sectors & Industries:

IN RE: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation

You will be tracking all:

News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes

First Filing

View recent docket activity »

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 17, 2012

    Bayer Pays $15M To Soothe Consumers In Aspirin MDL

    Bayer Corp. has agreed to pay $15 million to resolve class action claims that it misled consumers into believing its combination aspirin drugs had received regulatory approval, according to a settlement motion filed in New York federal court Wednesday.

Parties

To view the parties, take a free trial now.

Already a subscriber? Click here to login

Already have access?

  2. Forgot your password?
  4. Sign In

Get instant access to the one-stop news source for business lawyers

Required

Register